TLT Explains

New York Court Overturns $454 Million Fine Against Trump

By The Liberty Tribune Staff

Published: 9/12/2025 · Updated: 9/18/2025 · 5 min read

A appellate has overturned a former President Donald Trump, a decision that comes amid.

What's happening

New York Court Overturns $454 Million Fine Against Trump — The Trump administration announced Tuesday it would halt immigration applications from 19 countries, citing national security concerns. Following a suspected terrorist attack in Washington D.C. allegedly involving an Afghan national, U.S. Citizenship and Immigration Services (USCIS) has placed a hold on asylum applications from these nations. The countries identified include Afghanistan, Burma, Chad, Republic of the Congo, Equatorial Guinea, Eritrea, Haiti, Iran, Libya, Somalia, Sudan, Yemen, Burundi, Cuba, Laos, Sierra Leone, Togo, Turkmenistan, and Venezuela. Explainer Trump Administration Reassesses Approach to Sanctuary Officials Department of Homeland Security Secretary Kristi Noem emphasized the need for strict immigration controls, stating, "Our forefathers built this nation on blood, sweat, and the unyielding love of freedom—not for foreign invaders to slaughter our heroes." The administration's criteria for these countries is rooted in security concerns, particularly the inability to confirm proper vetting of immigrants. In addition to the 19 countries, some analysts argue that Mexico, China, and India should also be considered for travel restrictions. According to a 2023 report from CNN, Mexicans represent the largest group of immigrants in the U.S., followed by India and China. The report highlights that a significant portion of these individuals may be living in the country without authorization. Critics of immigration from Mexico point to incidents of civil unrest, where demonstrators displayed Mexican flags during protests against deportations. The recent agreement between the Trump administration and pharmaceutical companies Eli Lilly and Novo Nordisk aims to expand affordable coverage for obesity drugs, a move that has been met with both praise and skepticism.

What's at stake

While the initiative is expected to lower the prices of popular drugs like Ozempic and Wegovy, critics argue that the deal may ultimately benefit the pharmaceutical companies more than consumers. Explainer Trump Administration Reassesses Approach to Sanctuary Officials What the Trump obesity drug deal promises The announced that prices for Ozempic and Wegovy would decrease significantly, from $1,000 and $1,350 per month to $350 through a new direct-to-consumer platform called TrumpRx, set to launch next year. Additionally, Medicare prices for these drugs are projected to be $245, which is less than half of the prices proposed by the Biden administration. Supporters of the agreement argue that it could give uninsured or underinsured patients access to treatments that were previously out of reach, potentially improving for millions of Americans struggling with obesity. Why analysts say Big Pharma still comes out ahead However, a Wall Street Journal analysis suggests that these advertised discounts may not reflect the true cost dynamics in the pharmaceutical market. The effective prices that pharmaceutical companies receive after accounting for rebates and discounts are reportedly only 20% to 35% lower than current Medicare payments for Mounjaro, a drug used for diabetes. The direct-to-consumer model is expected to benefit those without insurance coverage for GLP-1 drugs, who currently face inflated prices. Yet, the pharmaceutical companies may only experience a modest reduction in net revenue. Analysts note that the companies are shifting their profit strategy from high margins on fewer customers to lower margins on a larger customer base, which could ultimately enhance their market position.

Recent protests against former President Donald Trump have highlighted a significant demographic shift within the Democratic Party, as participation appears to skew heavily toward older individuals. Reports from various locations indicate that the protests, dubbed "No Kings," featured predominantly older attendees, raising concerns about the party's appeal to younger voters. Explainer Trump Designates Antifa as Domestic Terrorist Organization Amid Protests in Oregon NBC Boston described the scene at one protest, noting, "This is an older crowd … A lot of white hair. You see Q-Tips as we used to call them in the business … not a lot of young people." This observation reflects a broader trend, as younger generations, particularly Gen Z, increasingly lean toward Republican candidates. A study by CIRCLE revealed that the youth vote was "more Republican and conservative in 2024," with economic issues being a primary concern driving this shift. The findings suggest that Gen Z is charting a different political course compared to Millennials, with recent data indicating that they are the "most pro-GOP generation alive." Lee Miringoff, director of the Marist University Institute for Public Opinion, noted that Trump resonates with voters dissatisfied with the current state of affairs. What to watch next is whether new filings, agency actions, votes, or court decisions change the timeline—and how officials respond in the weeks ahead.

Why it matters

The coverage highlights: 3 Countries That Should Be Next On Trump's Travel Ban List. The coverage highlights: House Subpoenas Jack Smith Over Arctic Frost Fishing Expedition. The coverage highlights: Jack Smith Ignored Constitutional Standards In Arctic Frost Lawfare. The coverage highlights: Comey, James Escape Justice For Now Thanks To 'Partisan Judge'. The coverage highlights: Why Trump's Obesity Drug 'Deal' Will Help Big Pharma Most Of All. The coverage highlights: Judge: Halligan Can't Prosecute Comey Since Trump Appointed Her.

Key facts & context

2025-12-04: 3 Countries That Should Be Next On Trump's Travel Ban List. 2025-12-03: House Subpoenas Jack Smith Over Arctic Frost Fishing Expedition. 2025-11-25: Jack Smith Ignored Constitutional Standards In Arctic Frost Lawfare. 2025-11-25: Comey, James Escape Justice For Now Thanks To 'Partisan Judge'. 2025-11-25: Why Trump's Obesity Drug 'Deal' Will Help Big Pharma Most Of All. 2025-11-24: Judge: Halligan Can't Prosecute Comey Since Trump Appointed Her. 2025-10-27: The Left Prefers A Rubble-Ridden White House To A Trump Win. 2025-10-20: Democrats Struggle to Attract Young Voters Amid Protests. 2025-10-09: Letitia James Indicted for Mortgage Fraud. 2025-09-04: Media Coverage of Trump and Biden's Health: A Comparative Analysis.

Timeline & key developments

Primary sources

nycourts.gov PDF